Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Bruker (BRKRP) Raw Materials (2016 - 2025)

Historic Raw Materials for Bruker (BRKRP) over the last 17 years, with Q3 2025 value amounting to $412.6 million.

  • Bruker's Raw Materials fell 499.65% to $412.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $412.6 million, marking a year-over-year decrease of 499.65%. This contributed to the annual value of $388.7 million for FY2024, which is 471.44% up from last year.
  • Per Bruker's latest filing, its Raw Materials stood at $412.6 million for Q3 2025, which was down 499.65% from $427.4 million recorded in Q2 2025.
  • Bruker's Raw Materials' 5-year high stood at $434.3 million during Q3 2024, with a 5-year trough of $218.7 million in Q4 2021.
  • In the last 5 years, Bruker's Raw Materials had a median value of $355.4 million in 2023 and averaged $344.9 million.
  • As far as peak fluctuations go, Bruker's Raw Materials surged by 3758.57% in 2022, and later crashed by 499.65% in 2025.
  • Quarter analysis of 5 years shows Bruker's Raw Materials stood at $218.7 million in 2021, then skyrocketed by 37.59% to $300.9 million in 2022, then increased by 23.36% to $371.2 million in 2023, then rose by 4.71% to $388.7 million in 2024, then grew by 6.15% to $412.6 million in 2025.
  • Its Raw Materials stands at $412.6 million for Q3 2025, versus $427.4 million for Q2 2025 and $398.0 million for Q1 2025.